Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026

Company to hold a conference call at 8AM ET on November 5, 2026 to review results and provide a corporate update SHELTON, Conn., Oct. 30, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on...

Read the full story at Intensity Therapeutics Inc. via PR Newswire (opens in a new tab)

Headline and summary from Intensity Therapeutics Inc. via PR Newswire; the full story is on the publisher's site. Nothing here is investment advice.